SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000936392-07-000456
Filing Date
2007-05-23
Accepted
2007-05-23 17:11:03
Documents
5
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q a30501e10vqza.htm 10-Q/A 533291
2 EXHIBIT 31.1 a30501exv31w1.htm EX-31.1 5610
3 EXHIBIT 31.2 a30501exv31w2.htm EX-31.2 5610
4 EXHIBIT 32.1 a30501exv32w1.htm EX-32.1 3290
5 EXHIBIT 32.2 a30501exv32w2.htm EX-32.2 3603
  Complete submission text file 0000936392-07-000456.txt   552819
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33093 | Film No.: 07874560
SIC: 2834 Pharmaceutical Preparations